latest publications

Recent Development of Nanomaterials for Transdermal Drug Delivery

M. Y. Leong, Y. L. Kong, K. Burgess, W. F. Wong, G. Sethi, C. Y. Looi

Biomedicines, 2023, 11, 1124

Novel near-infrared Aza-BODIPY-based fluorescent and colorimetric sensor for highly selective detection of Au3+ in aqueous media, human skin and brain cells

D. Plaisathit, K. Setthakarn, Jitnapa Sirirak, A. Kamakew, P. Maitarad, K. Burgess and N. Wanichacheva

J. Photochem. Photobio. A., 2023, 441

Bicyclic Schellman Loop Mimics (BSMs): Rigid Synthetic C-Caps For Enforcing Peptide Helicity

T. Mi, D. Nguyen, K. Burgess

ACS Cent. Sci., 2023, 9, 300 – 306

Cytotoxicities of Tumor-Seeking Dyes: Impact on Future Clinical Trials

S. M. Usama, Z. Gao, M. Arancillo, and K. Burgess

ChemMedChem.2023, e20200561


A, B, C’s of Trk Receptors and Their Ligands in Ocular Repair

Z. Yu, S. Joy, T. Mi, G. Yazsanpanah, K. Burgess, and C. De Paiva

Int. J. Mol. Sci.2022, 23, 14069

Piptide Chemotypes For Perturbation Of The Interaction Of Urokinase With Its Receptor

M. Arancillo, C. M. Lin, K. Burgess

J. Med. Chem.2022, 65, 12925 – 12932

New, Potent, Small Molecule Agonists of Tyrosine Kinase Receptors Improve Dry Eye Disease

Z. Yu, S. Joy, T. Mi, G. Yazsanpanah, K. Burgess, and C. De Paiva

Front. Med. Opthal.2022, 9, 937142

Synthetic Helical Peptide Capping Strategies

J. Whisenant, K. Burgess

Chem. Soc. Rev.2022, 51, 5795-5804

QuatCy-I2 And MHI-I2 In Photodynamic Therapy

S. Thavornpradit, S. M. Usama, G. K. Park, H. S. Choi, K. Burgess

ACS Med. Chem. Lett.2022, 13, 470-474

A Fluorescent PARP Inhibitor Applied To Intracranial Glioblastoma: Accumulation And Persistence In Vivo

Z. Gao, Z. Yang, Z. Li, K. Burgess

ACS Med. Chem. Lett.2022, 13, 911 – 915

Antibody-Dependent Cellular Phagocytosis of Tropomyosin Receptor Kinase C (TrkC) Ex-pressing Cancer Cells for Targeted Immunotherapy

P. S. Lai, S. M. Usama, L.-V. Kiew, H. B. Lee, L. Y. Chung, K. Burgess, C. S. Kue

Cancer Immunol., Immunother., 2022, 71, 2099-2018

Small Molecule Peptidomimetic Trypsin Inhibitors: Validation Of An EKO Binding Mode, But With A Twist

R.-L. Lyu, S. Joy, C. Packianathan, A. Laganowsky, K. Burgess

Org. Biomol. Chem., 2021, 20, 2075-2080